NUTRITIONAL GROWTH SOLUTIONS LTD — Capital/Financing Update 2021

Aug 29, 2021

ASX Announcement 30 August 2021

==> picture [113 x 92] intentionally omitted <==

NUTRITIONAL GROWTH SOLUTIONS RAISES $5 MILLION VIA PLACEMENT TO ACCELERATE GLOBAL GROWTH STRATEGY

HIGHLIGHTS:

• Firm commitments received to raise A$5 million via a Placement (before costs) at 21.5 cents per share, which includes 1 free option for every 4 shares subscribed

• Strong support from new institutional and sophisticated investors, as well as from existing shareholders

• Proceeds to accelerate global growth initiatives including, sales and marketing activities in the United States and China, inventory investment to support increasing sales demand, and fund clinical trials

Nutritional Growth Solutions Ltd. (“the Company” or “NGS”, ASX:NGS), a global nutrition company that creates clinically proven supplements to support growth development in young people is pleased to announce the successful completion of a share placement, raising $5 million (before costs) at 21.5 cents per share ( Placement ).

The proceeds from the Placement will be used to accelerate brand equity building for Healthy Heights® in the lucrative Chinese and US markets, invest in inventory to support increasing sales and fund clinical testing on new products in development.

Nutritional Growth Solutions CEO and Managing Director, Liron Fendell said:

“We are pleased with the level of support shown by existing shareholders, as well as new institutional and new sophisticated investors in this Placement, and for their confidence in our three-pillar growth strategy to grow Healthy Heights® into a global household name.”

“We are placing increased focused on the US and Chinese markets where we see the most potential for Healthy Heights® and will immediately begin building brand equity in each region to increase awareness and drive demand for our range of patented products that have been clinically proven to increase the rate of growth in young people.”

“I am excited to lead Nutritional Growth Solutions through our next stage of growth. With a refreshed brand, new products to market and new regions to market them in, along with an A-team of industry veterans, I have never been more confident in our ability to deliver on our strategy to ensure every young person reaches their full potential.”

Nutritional Growth Solutions Ltd. ARBN 642 861 774 Israel: 4 Berkovich Street, Tel Aviv 6423806 Australia (Registered Local Agent): C/- Level 5, 126 Phillip Street, Sydney NSW 2000

ASX Code: NGS

www.ngsolutions.co

==> picture [113 x 92] intentionally omitted <==

“I want to thank all who have made the Placement such a success, and I look forward to delivering on the attractive opportunities in front of us.”

Placement Details

The Placement was led by Baker Young Limited and was strongly supported by the Company’s existing shareholders, supporting brokers as well as several new institutional and sophisticated investors, raising $5 million (before costs). The Placement comprises a total offer of 23.2 million fully paid ordinary shares in Nutritional Growth Solutions at an issue price of 21.5 cents per share. The issue price represents a discount of 12% to the Wednesday 25 August 2021 VWAP of 24.4 cents, and a 14.5% discount to the 7-day VWAP prior to the trading halt on 26 August 2021.

22.8m shares will be issued by using the Company’s existing capacities under Listing Rules 7.1A and 7.1. The remaining 0.4m shares ($93,000) have been subscribed for by Directors of NGS and are subject to shareholder approval.

Shares subscribed for in the Placement include 1 free option (“Options”) for every 4 shares subscribed, exercisable at 27.0 cents per share with a 2 year expiry. The Options are intended to be listed on the ASX and are subject to shareholder approval.

Settlement of the Placement is expected to occur on 3 September 2021 with the new shares expected to be allotted and to commence trading on the ASX on 6 September 2021. New shares issued under the Placement will rank equally with the Company’s existing ordinary shares on issue.

This announcement has been authorised for release by the Board of Directors of Nutritional Growth Solutions Ltd.

-ends-

For more information:

Mr Brian Leedman Chairman, Nutritional Growth Solutions P: +61 (0) 412 281 780 E: bleedman@ngsolutions.co

Media

Tristan Everett Market Eye P: +61 403 789 096 E: tristan.everett@marketeye.com.au

Nutritional Growth Solutions Ltd. – ASX Announcement 30 August 2021

Page 2 of 3

==> picture [113 x 92] intentionally omitted <==

About Nutritional Growth Solutions

Nutritional Growth Solutions is a global nutritional health company focused on the well-being of children. NGS develops, produces and sells clinically tested nutritional supplement formulae for children following 20 years of medical research into pediatric nutrition at Schneider Children’s Medical Centre, Israel’s largest pediatric hospital. The nutritional supplements market has experienced tremendous growth in recent years, but most attention has been focused on adult users and children under three years of age. The three to twelve-year-old consumers represent a larger market opportunity and NGS is highly differentiated from its competitors with clinically tested products and an expanding product portfolio to capture this market opportunity.

ngsolutions.co

Nutritional Growth Solutions Ltd. – ASX Announcement 30 August 2021

Page 3 of 3